UK markets open in 2 hours 28 minutes
NIKKEI 225
38,342.34 +139.97 (+0.37%) HANG SENG
18,538.57 +224.71 (+1.23%) CRUDE OIL
79.42 +0.43 (+0.54%) GOLD FUTURES
2,320.70 -1.60 (-0.07%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,249.32 -1,030.39 (-2.05%)
Roche Holding AG (0QQ6.L)
LSE - LSE Delayed price. Currency in CHF
Add to watchlist
At close: 05:44PM BST
| Previous close | 239.25 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 9,031 |
| Market cap | 2.07B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 0.15 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript May 7, 2024 Halozyme Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is [Perla] (ph), and I’ll be your conference operator today. […]
- Thomson Reuters StreetEvents
Q1 2024 Halozyme Therapeutics Inc Earnings Call
Q1 2024 Halozyme Therapeutics Inc Earnings Call
- Zacks
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
© 2024 Yahoo. All rights reserved.